BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2013
View Archived Issues
Zebrafish model confirms novel gene involved in the regulation of thrombocyte formation
Read More
A non-invasive, diagnostic, and prognostic method to detect successful renal transplants
Read More
Confirmation of the efficacy of a small-molecule inhibitor against a protozoan parasitic infection
Read More
Targeting factor XII for anticoagulation tested with CSL-3F7
Read More
Fab demonstrates potential for reversing dabigatran-induced anticoagulation and bleeding
Read More
Prosensa receives E.U. FP7 research grant for development of DMD candidate
Read More
Aegerion obtains European approval for Lojuxta in HoFH
Read More
TechnoVax receives NIH grant to develop universal flu vaccine
Read More
Cancer Research Technology, Institute of Cancer Research and Merck Serono form alliance
Read More
La Jolla Institute extends collaboration with KKC
Read More
Teijin Pharma and Amgen to develop novel therapies for autoimmune diseases
Read More
Bionomics and Merck & Co. to develop candidates for chronic pain
Read More
Serina Therapeutics forms research agreement with the Scripps Research Institute
Read More
Polyphor and Boehringer Ingelheim advance macrocyclic drug discovery collaboration
Read More
NIH award supports Arisaph's development of small-molecule immune modulators
Read More
OncoGenex begins phase II trial evaluating OGX-427 in NSCLC
Read More
Pivotal trial of Exparel in intercostal nerve block does not meet primary endpoint
Read More
ImmunoGen gains IND clearance from FDA for novel EGFR-targeting antibody-drug conjugate
Read More
ViroPharma discontinues phase II trial of subcutaneous Cinryze combined with rHuPH20
Read More
Daiichi Sankyo updates developments of first quarter fiscal 2013
Read More
CovX Technologies patents novel monoclonal antibody conjugates
Read More
U.S. group discloses new miRNA-196a antagonists for cancer
Read More
FDA expands age indication for Menveo quadrivalent meningococcal vaccine
Read More